BioCatalyst

Satralizumab — catalyst calendar

2 verified catalyst event(s) referencing Satralizumab, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-26
in 20d
ESTIMATED
 READOUT
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular D
Phase 2 · Duchenne Muscular Dystrophy
 Hoffmann-La Roche Satralizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12-16
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodyn
Phase 3 · NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis
 Hoffmann-La Roche Satralizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.